| abstract |
The present invention is based on the unexpected discovery that bismuth-containing compounds are effective in the treatment of inflammation of the oral mucosa in a mammal. In one of its aspects, the invention therefore relates to a method for treating inflammation of the oral mucosa, which consists in administering an effective amount of a pharmaceutically acceptable compound containing bismuth, such as a bismuth salt or a complex of bismuth. In a preferred embodiment, the bismuth compound is an organic or inorganic salt such as bismuth subsalicylate, bismuth subgallate, bismuth aluminate, bismuth citrate, bismuth subcitrate, bismuth carbonate, bismuth subcarbonate, bismuthate tripotassium di-citrate, bismuth nitrate, bismuth subnitrate, bismuth tartrate and mixtures of the above, preferably bismuth subsalicylate and bismuth subgallate. |